MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $38,777,000 | +39.8% | 643,056 | +6.6% | 0.04% | +32.3% |
| Q1 2016 | $27,730,000 | -3.5% | 603,075 | +1.5% | 0.03% | -3.1% |
| Q4 2015 | $28,726,000 | +13.3% | 594,241 | -0.3% | 0.03% | +3.2% |
| Q3 2015 | $25,343,000 | +649.8% | 596,316 | +1915.1% | 0.03% | +675.0% |
| Q2 2015 | $3,380,000 | +0.1% | 29,593 | +13.2% | 0.00% | 0.0% |
| Q1 2015 | $3,376,000 | +228.7% | 26,153 | +153.6% | 0.00% | +300.0% |
| Q4 2014 | $1,027,000 | – | 10,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |